<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Medical Sciences Division</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2"><gtr:id>F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2</gtr:id><gtr:firstName>Sten</gtr:firstName><gtr:otherNames>Eirik</gtr:otherNames><gtr:surname>Jacobsen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501838"><gtr:id>AF63E048-EF55-40BA-B211-714B52C15756</gtr:id><gtr:title>Strategic Skills Award</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501838</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2009-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>999868</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>Anthony (Tony) Green</gtr:description><gtr:id>73CA5BF6-8F79-4699-87BF-B13E55B19307</gtr:id><gtr:impact>-</gtr:impact><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Adam Mead</gtr:description><gtr:id>013CAB56-5EA9-4C26-8443-628C43908C0B</gtr:id><gtr:impact>Multiple publications listed in outcome</gtr:impact><gtr:partnerContribution>Molecular analysis of hematopoiesis</gtr:partnerContribution><gtr:piContribution>Mouse models of normal and malignant hematopoiesis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Sten Linnarsson</gtr:description><gtr:id>D0F4504D-6242-4C94-A517-E5C226811BEF</gtr:id><gtr:impact>Publications as listed above</gtr:impact><gtr:partnerContribution>Sten Linnarsson is a world leader in single cell RNA sequencing and his input has been key to several of our reported publications utilising small cell number or single cell RNA sequencing (Cell Stem Cell 2013; Cancer Cell 2014)</gtr:partnerContribution><gtr:piContribution>Single cell analysis of stem and progenitor cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Marella de Bruijn</gtr:description><gtr:id>07E15239-8E77-4E9F-9032-6AB758BDE596</gtr:id><gtr:impact>Several publications, including Boiers et al, Cell Stem Cell 2013 and Luc et al, Nature Immunology 2012</gtr:impact><gtr:partnerContribution>Expertise in mouse developmental hematopoiesis</gtr:partnerContribution><gtr:piContribution>Mouse Models for stem and progenitor biology</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Claus Nerlov</gtr:description><gtr:id>0F627A6D-9D50-4C18-9CC1-4972231C3237</gtr:id><gtr:impact>As listed in outcome multiple high impact joint publications</gtr:impact><gtr:partnerContribution>Mouse genetic models of normal and malignant hematopoiesis</gtr:partnerContribution><gtr:piContribution>stem and progenitor cell characterisation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Rickard Sandberg</gtr:description><gtr:id>97B90864-22BC-491E-B57F-783A362EE445</gtr:id><gtr:impact>-</gtr:impact><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Anna Katharina (Katja) Simon</gtr:description><gtr:id>9048F63B-2CA2-4739-B5C2-C4566E954707</gtr:id><gtr:impact>-</gtr:impact><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Characterisation and regulation of distinct hematopoietic stem and progenitor cells</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9CE7060F-A1DA-407C-851C-BA781B33DABE</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2766300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Programme Grant</gtr:department><gtr:description>Regulation of normal hematopoiesis</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>502166A6-D97C-4297-A2E6-7DF4B443D2E9</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93000000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Establishment of Hematopoietic Stem Cell Research Program at the Karolinska Institute</gtr:description><gtr:fundingOrg>Swedish Research Council</gtr:fundingOrg><gtr:id>A060BC1B-2FD8-4EA1-B5E3-13C5EA9AAA0D</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45250000</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Characterization, surveillance and targeting of cancer stem cells</gtr:description><gtr:end>2021-07-02</gtr:end><gtr:fundingOrg>Knut and Alice Wallenberg Foundation</gtr:fundingOrg><gtr:id>E4DFEEF9-EF8D-4F72-AD4B-FBDFBD409A5E</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>The John Fell Fund</gtr:department><gtr:description>Acquisition of high-end FACS cell sorter for WIMM FACS facility.</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>EFF9E2E7-50ED-4261-88DD-2B92783DD4DC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Professor/ Prize in Medicine 2015</gtr:description><gtr:end>2025-12-02</gtr:end><gtr:fundingOrg>Torsten S?derbergs Stiftelse</gtr:fundingOrg><gtr:id>D717AF1A-5DBC-437B-B82C-2D02AD9A13C3</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Society for Stem Cell Research (ISSCR) McEwen Award for Innovation selection committee</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>AEAF740B-08B2-4BD4-B5F4-BFED065F881D</gtr:id><gtr:impact>International Society for Stem Cell Research (ISSCR) McEwen Award for Innovation selection committee</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.isscr.org</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Scientific Advisory Board, Stem Cell Institute, Leuven, Belgium</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6465C5E6-BE76-44AC-99FB-59CDA6B3ECEF</gtr:id><gtr:impact>Member of Scientific Advisory Board, Stem Cell Institute, Leuven, Belgium (Director Professor Catherine Verfaillie) - Starting date 2005-date</gtr:impact><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.kuleuven.be/samenwerking/scil</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Board of Center of Excellence in Developmental Biology, Karolinska Institute</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8242B52E-56DC-460E-8301-2716F977B1BB</gtr:id><gtr:impact>Member of Board of Center of Excellence in Developmental Biology, Karolinska Institute (Director, Professor Urban Lendahl)</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Permanent member of Cell and Developmental Biology Expert Review Group, Wellcome Trust</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0E5D462D-BD04-42F3-8DBD-E0C4BFC9AB34</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman of Committee for allogeneic transplantations and cell therapies, Karolinska University Hospital</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FE4F8C0F-105C-49C0-9BFA-7434DC7DF7D4</gtr:id><gtr:impact>Allogeneic transplantations and cell therapies.</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of scientific advisory board of GAMBRO, Sweden</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>05534AF6-F20F-4635-844B-D99A63E81970</gtr:id><gtr:impact>Member of scientific advisory board of GAMBRO, Sweden</gtr:impact><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Board of Center for Molecular Medicine, Karolinska Institutet</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>824F4F09-2415-40AC-B527-1CCABF95088E</gtr:id><gtr:impact>Member of Board of Center for Molecular Medicine, Karolinska Institutet</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>OX Stem Oncology</gtr:companyName><gtr:description>Establishment (as co-founder) of a spin-off company for development of targeting of cancer stem cells.</gtr:description><gtr:id>63428103-2AB7-4706-A9FB-F078DFF41250</gtr:id><gtr:impact>Development of therapeutic targeting of cancer stem cells.</gtr:impact><gtr:yearCompanyFormed>2016</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0D5B501-D427-4D87-A5D5-CAF9F40B44BD"><gtr:id>E0D5B501-D427-4D87-A5D5-CAF9F40B44BD</gtr:id><gtr:title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9dcbcbb174ef85060f893c5185d2dbd0"><gtr:id>9dcbcbb174ef85060f893c5185d2dbd0</gtr:id><gtr:otherNames>Sanjuan-Pla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44659F88-E45D-42B6-9006-7D5CD94FED17"><gtr:id>44659F88-E45D-42B6-9006-7D5CD94FED17</gtr:id><gtr:title>Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5020f1fc79f56da95e57541d9bb5da4"><gtr:id>d5020f1fc79f56da95e57541d9bb5da4</gtr:id><gtr:otherNames>B?iers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D173A85-66B4-4983-B284-D6D69AEB08FB"><gtr:id>9D173A85-66B4-4983-B284-D6D69AEB08FB</gtr:id><gtr:title>FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/296683E7-45E5-4CF3-8DF6-ADDE0C8610CD"><gtr:id>296683E7-45E5-4CF3-8DF6-ADDE0C8610CD</gtr:id><gtr:title>A lineage of myeloid cells independent of Myb and hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6611fb1d82a723ab6d7bd458727956ee"><gtr:id>6611fb1d82a723ab6d7bd458727956ee</gtr:id><gtr:otherNames>Schulz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99B65E1B-43AF-451E-B1A4-2D4DBE5582E8"><gtr:id>99B65E1B-43AF-451E-B1A4-2D4DBE5582E8</gtr:id><gtr:title>DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58c4f93f6c3ff9963ccd99cdcb974746"><gtr:id>58c4f93f6c3ff9963ccd99cdcb974746</gtr:id><gtr:otherNames>Br?ske AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A05318F5-53E4-4914-9E10-02DDA4CDEBFA"><gtr:id>A05318F5-53E4-4914-9E10-02DDA4CDEBFA</gtr:id><gtr:title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bc2a33653d404809acfd047a1a3aa3c"><gtr:id>6bc2a33653d404809acfd047a1a3aa3c</gtr:id><gtr:otherNames>Luis TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E0C24A3-D691-4C94-B475-9DB8D847DECD"><gtr:id>2E0C24A3-D691-4C94-B475-9DB8D847DECD</gtr:id><gtr:title>Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea55234dfaedb9fee2f3d68e527bc3e3"><gtr:id>ea55234dfaedb9fee2f3d68e527bc3e3</gtr:id><gtr:otherNames>Liuba K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/905CD1C5-4BC0-4F6F-B94E-18C96CE79DBC"><gtr:id>905CD1C5-4BC0-4F6F-B94E-18C96CE79DBC</gtr:id><gtr:title>FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c169282b2de3fa3fcd1c314b1a84b375"><gtr:id>c169282b2de3fa3fcd1c314b1a84b375</gtr:id><gtr:otherNames>Jensen CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E45D36B2-64D0-4EE2-A37F-0BCB26C1A394"><gtr:id>E45D36B2-64D0-4EE2-A37F-0BCB26C1A394</gtr:id><gtr:title>Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b160b7da3fb43d8dc5b4fbbfe805f7e1"><gtr:id>b160b7da3fb43d8dc5b4fbbfe805f7e1</gtr:id><gtr:otherNames>M?nsson R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7B1311C-AD11-4DF2-A4DE-92D6C450E0F5"><gtr:id>F7B1311C-AD11-4DF2-A4DE-92D6C450E0F5</gtr:id><gtr:title>GATA3 is redundant for maintenance and self-renewal of hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA3EE440-6A8F-47D3-A61E-573CE68A15B1"><gtr:id>AA3EE440-6A8F-47D3-A61E-573CE68A15B1</gtr:id><gtr:title>Dicer is selectively important for the earliest stages of erythroid development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8122DBA4-EC64-4C33-B058-078A3BB173B0"><gtr:id>8122DBA4-EC64-4C33-B058-078A3BB173B0</gtr:id><gtr:title>The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/863c8044fc8bc8103f03fb2384b7e08c"><gtr:id>863c8044fc8bc8103f03fb2384b7e08c</gtr:id><gtr:otherNames>Luc S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74EF15BB-FD3D-469D-A855-32F149382466"><gtr:id>74EF15BB-FD3D-469D-A855-32F149382466</gtr:id><gtr:title>Persistent malignant stem cells in del(5q) myelodysplasia in remission.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a96d892dd559c3e7d3575f4ae7396778"><gtr:id>a96d892dd559c3e7d3575f4ae7396778</gtr:id><gtr:otherNames>Tehranchi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F4E95595-98FA-4C53-8701-B1E06B1FCF7C"><gtr:id>F4E95595-98FA-4C53-8701-B1E06B1FCF7C</gtr:id><gtr:title>Transcriptional repression of Gata3 is essential for early B cell commitment.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384b11b2c521a3ead015d219baa5bdbc"><gtr:id>384b11b2c521a3ead015d219baa5bdbc</gtr:id><gtr:otherNames>Banerjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70A91B13-CAC0-40A9-BF08-FAECA975A5E2"><gtr:id>70A91B13-CAC0-40A9-BF08-FAECA975A5E2</gtr:id><gtr:title>Down-regulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/863c8044fc8bc8103f03fb2384b7e08c"><gtr:id>863c8044fc8bc8103f03fb2384b7e08c</gtr:id><gtr:otherNames>Luc S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01EF7978-7A41-447D-BC6B-38B0140A6CC8"><gtr:id>01EF7978-7A41-447D-BC6B-38B0140A6CC8</gtr:id><gtr:title>TSLP-mediated fetal B lymphopoiesis?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c169282b2de3fa3fcd1c314b1a84b375"><gtr:id>c169282b2de3fa3fcd1c314b1a84b375</gtr:id><gtr:otherNames>Jensen CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/801F380B-0EE1-4DFE-928A-156066C53888"><gtr:id>801F380B-0EE1-4DFE-928A-156066C53888</gtr:id><gtr:title>Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12afb9b38ce2e9ee422a58cd5a8fe34d"><gtr:id>12afb9b38ce2e9ee422a58cd5a8fe34d</gtr:id><gtr:otherNames>Pronk CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E523403F-702A-459A-B479-F0ABD2FA6177"><gtr:id>E523403F-702A-459A-B479-F0ABD2FA6177</gtr:id><gtr:title>Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5020f1fc79f56da95e57541d9bb5da4"><gtr:id>d5020f1fc79f56da95e57541d9bb5da4</gtr:id><gtr:otherNames>B?iers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F9FB7D4-43CA-497A-BA64-B00CBA2BC5BD"><gtr:id>8F9FB7D4-43CA-497A-BA64-B00CBA2BC5BD</gtr:id><gtr:title>Potential risks of bone marrow cell transplantation into infarcted hearts.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69e0ffc6c8d9d2acbe55ee2a9725ba3f"><gtr:id>69e0ffc6c8d9d2acbe55ee2a9725ba3f</gtr:id><gtr:otherNames>Breitbach M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F8A3E7E-F437-4940-B426-12D8FCE85A89"><gtr:id>5F8A3E7E-F437-4940-B426-12D8FCE85A89</gtr:id><gtr:title>Impact of isolated germline JAK2V617I mutation on human hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/011F9E2B-FDBF-4201-B0D6-6ADECF58B9CC"><gtr:id>011F9E2B-FDBF-4201-B0D6-6ADECF58B9CC</gtr:id><gtr:title>Kit regulates maintenance of quiescent hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/32f9bf9dccc3a001d140d986bafc90d9"><gtr:id>32f9bf9dccc3a001d140d986bafc90d9</gtr:id><gtr:otherNames>Thor?n LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8DDC8672-0D1A-4396-BB25-D7C1C2DB3E42"><gtr:id>8DDC8672-0D1A-4396-BB25-D7C1C2DB3E42</gtr:id><gtr:title>Primitive Embryonic Macrophages are Required for Coronary Development and Maturation.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a745ead6e86499980d0b10512f52e0cb"><gtr:id>a745ead6e86499980d0b10512f52e0cb</gtr:id><gtr:otherNames>Leid J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9BA93DB-0E63-4DDB-82E8-5452B8F63993"><gtr:id>A9BA93DB-0E63-4DDB-82E8-5452B8F63993</gtr:id><gtr:title>A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e241df9506cc57c225f4d67f9f5101c"><gtr:id>5e241df9506cc57c225f4d67f9f5101c</gtr:id><gtr:otherNames>Buono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DCE6F81-4E69-4F4D-B19F-BE5C0D7C66EC"><gtr:id>0DCE6F81-4E69-4F4D-B19F-BE5C0D7C66EC</gtr:id><gtr:title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEE3F00C-725A-4E41-BE66-6C7E54A66034"><gtr:id>FEE3F00C-725A-4E41-BE66-6C7E54A66034</gtr:id><gtr:title>Germline JAK2 mutation in a family with hereditary thrombocytosis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60762FFA-DC71-4222-B236-558729FCCE96"><gtr:id>60762FFA-DC71-4222-B236-558729FCCE96</gtr:id><gtr:title>Cited2 is an essential regulator of adult hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53a50e6d0799dc3fd6dbb34f263987df"><gtr:id>53a50e6d0799dc3fd6dbb34f263987df</gtr:id><gtr:otherNames>Kranc KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09824D45-F0FA-4E8E-811D-A8F66741141D"><gtr:id>09824D45-F0FA-4E8E-811D-A8F66741141D</gtr:id><gtr:title>Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86F9FA5E-34E1-4E56-A88B-EA76E2C3AD72"><gtr:id>86F9FA5E-34E1-4E56-A88B-EA76E2C3AD72</gtr:id><gtr:title>FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FB45830-1D39-443E-B872-9D7C3273D7E9"><gtr:id>3FB45830-1D39-443E-B872-9D7C3273D7E9</gtr:id><gtr:title>Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7c907488f14fd30f5bc6cabdea40dc8"><gtr:id>d7c907488f14fd30f5bc6cabdea40dc8</gtr:id><gtr:otherNames>Bardini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA17EA3E-1A75-4775-BB39-1AD6738462E0"><gtr:id>AA17EA3E-1A75-4775-BB39-1AD6738462E0</gtr:id><gtr:title>FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C007B595-6351-45C2-A460-4F2BBF7317CC"><gtr:id>C007B595-6351-45C2-A460-4F2BBF7317CC</gtr:id><gtr:title>Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T-cell development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c169282b2de3fa3fcd1c314b1a84b375"><gtr:id>c169282b2de3fa3fcd1c314b1a84b375</gtr:id><gtr:otherNames>Jensen CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E16327D-3C48-43B0-8EC0-8AD794A4AB2A"><gtr:id>0E16327D-3C48-43B0-8EC0-8AD794A4AB2A</gtr:id><gtr:title>Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8741af256400e816e021605f02d2af77"><gtr:id>8741af256400e816e021605f02d2af77</gtr:id><gtr:otherNames>Nygren JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95FC4214-5E33-45D5-8ED3-7D2008B4D099"><gtr:id>95FC4214-5E33-45D5-8ED3-7D2008B4D099</gtr:id><gtr:title>Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/77b898934872e74bda9b511e73d71ee7"><gtr:id>77b898934872e74bda9b511e73d71ee7</gtr:id><gtr:otherNames>Zriwil A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70EED560-64D6-496F-AD64-1C03D0766F7F"><gtr:id>70EED560-64D6-496F-AD64-1C03D0766F7F</gtr:id><gtr:title>Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c678f61d9baba78039fd689d1985a666"><gtr:id>c678f61d9baba78039fd689d1985a666</gtr:id><gtr:otherNames>Woll PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75842C88-8C0C-44C5-A7E7-EBB64463FE41"><gtr:id>75842C88-8C0C-44C5-A7E7-EBB64463FE41</gtr:id><gtr:title>Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a4de4f25ab06ec8486a5297e7e5328d"><gtr:id>3a4de4f25ab06ec8486a5297e7e5328d</gtr:id><gtr:otherNames>Goardon N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8FD0CBC-D57A-4682-A189-F7EC13807096"><gtr:id>D8FD0CBC-D57A-4682-A189-F7EC13807096</gtr:id><gtr:title>Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/799c04ab6ff2a7dd1e19bc6b6c0a7d88"><gtr:id>799c04ab6ff2a7dd1e19bc6b6c0a7d88</gtr:id><gtr:otherNames>Qian H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32082530-D96E-4FF6-AE0D-BFAA48F8E383"><gtr:id>32082530-D96E-4FF6-AE0D-BFAA48F8E383</gtr:id><gtr:title>Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DCC686F0-AE94-4B1F-9D89-ED4D75760603"><gtr:id>DCC686F0-AE94-4B1F-9D89-ED4D75760603</gtr:id><gtr:title>Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9552171-C9EF-4756-BC8A-AD521886BE22"><gtr:id>B9552171-C9EF-4756-BC8A-AD521886BE22</gtr:id><gtr:title>Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/181ab8654c10f4d7f7d687896f4c2130"><gtr:id>181ab8654c10f4d7f7d687896f4c2130</gtr:id><gtr:otherNames>Sitnicka E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501838</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>